Here is the latest stock price and chart of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Nov 21, 2024 (Close) | ||
---|---|---|---|
Price (Rs)1,465.30 | Open (Rs) 1,494.45 | High (Rs) 1,494.45 | Low (Rs) 1,458.85 |
% Change-1.81 | Volume 7,150 | Value (Rs) 10,533,827 | 52-Week H/L 1,830.05 / 761.15 |
Live NSE Quotes | Nov 21, 2024 (Close) | ||
---|---|---|---|
Price (Rs)1,466.40 | Open (Rs) 1,492.65 | High (Rs) 1,494.20 | Low (Rs) 1,458.55 |
% Change-1.76 | Volume 421,354 | Value (Rs) 619,844,509 | 52-Week H/L 1,830.95 / 761.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.81% | 1 Month -14.57% | 3 Months -12.80% | 1 Year 88.44% | 5 Years (CAGR)* 33.19% | 10 Years (CAGR)* 5.99% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* -35.21 | P/E Ratio (x) NM | Market Cap (Rs m) 413,490.37 | P/BV (x) 4.99 | Dividend Yield (%) 0.17 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
GLENMARK PHARMA last traded price was down 1.8% to Rs 1,465.3 on the BSE. On the NSE, GLENMARK PHARMA last traded price was down 1.8% to Rs 1,466.4. The total volume of shares traded was 0.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.1%. And the benchmark S&P BSE SENSEX was at 77,155.8 (down 0.5%).
Over the last 30 days, the GLENMARK PHARMA share price is down 14.6%. And over the last one year, GLENMARK PHARMA share price is up 86.6%.
The current market capitalisation of GLENMARK PHARMA stands at Rs 413,490.37 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of September 2024, company promoters held 46.65% stake in GLENMARK PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of GLENMARK PHARMA.
The last traded price of GLENMARK PHARMA was Rs 1,465.3 on the BSE, down 1.8% over the previous close. On the NSE, GLENMARK PHARMA last traded price was down 1.8% at Rs 1,466.4.
The current market capitalisation of GLENMARK PHARMA stands at Rs 413,490 m. For more information, check out the list of top 100 companies in India in terms of market cap.
GLENMARK PHARMA had an EPS of Rs -35.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 12.6.
For the financial year 2024, GLENMARK PHARMA declared dividend amounting to Rs 2.5 per share. At the current price of Rs 1,465.3, this results in a dividend yield of 0.2%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.